15.05.2023
Keltie is delighted to announce that Dr Jonathan Goodacre is a partner of the firm as of 1st May 2023.
Thank you
Jonathan will also lead the firm’s Cambridge office, where he has been based for several years now. Jonathan has been with Keltie since joining the patent profession and has become an integral part of the Life Sciences and Chemistry team. He has wide range of clients in the pharmaceuticals, cell therapy and agritech sectors and is looking to grow this practice further within the East of England.
Keltie partner, Devanand Crease, says “I have worked closely with Jonathan for over a decade. He has a great touch with clients and really goes the extra mile to seek out a commercial solution for them. This is what makes him a natural choice to lead the firm’s expansion in Cambridge and East of England.”
Jonathan said “It is an honour and privilege to be made partner at a firm where I started and learnt the profession. I am truly grateful to work with the same great people who have made this journey possible and who have supported me every step of the way. Keltie is a fantastic place to work where the values instilled in us all by our founder, David Keltie, remain strong. While my focus going forward will be in Cambridge and the East of England, we are one firm – and a great one at that!”
For 35 years, Keltie has sought to break the mould of traditional IP firms by creating an environment where talented individuals can enjoy building great relationships with exceptional clients. In that time, we have grown a diverse partnership across the patent and trademark practice. A partnership that continues to advance the inclusive ideals that founded the firm. Keltie attorneys work on the full spectrum of clients, from start-ups to multinational corporations. We value the relationships with our clients and work hard to build a level of understanding that allows us to anticipate challenges, as well as see opportunities. We are proud that Keltie attorneys are unique and it is our uniqueness that allows us to build outstanding IP relationships across the UK, Ireland, Europe and beyond.
12.03.2025
IP and SpaceThe space sector has seen remarkable advancements in recent years, with innovations spanning propulsion systems, life support technologies, advanced navigation, telecommunications, and space farming.
29.04.2025
Case Law Review: Board of Appeal Decision T 1741/22Patent applications related to data processing often fall foul of the EPO’s exclusions on “mathematical methods”. Applicants in the MedTech space in particular may find it far easier to protect the hardware in their wearable devices and tools than to protect the software that processes and analyses that data. A recent board of appeal decision T 1741/22 seems to contradict the Guidelines for Examination and previous Board of Appeal decisions. This decision may shed some light on how the EPO may approach these data processing applications in future.
Thank you